Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sanofi SA Receives Positive Recommendation from European Medicines Agency for New Multiple Sclerosis Pill Aubagio -Reuters


Friday, 22 Mar 2013 08:40am EDT 

Reuters reported that Sanofi SA announced that its new multiple sclerosis pill Aubagio have received positive recommendation from the European Union. 

Company Quote

76.35
-0.638 -0.83%
11:09am EDT